VIPR1 and colonic neoplasm: Regarding the GI tract, colon cancer tissue overexpresses VPAC1: in 35% of well-differentiated, 65% of moderately differentiated, and 87% of poorly differentiated colon cancers111, predicting tumor differentiation can be accomplished by measuring VPAC1 levels.